Terry Murdock Net Worth & Insider Trades

Terry Murdock - Chief Operating Officer, G1 Therapeutics, Inc

As of January 5, 2023

What is Terry Murdock's Net Worth?

The current estimated net worth of G1 Therapeutics, Inc's Chief Operating Officer, Terry Murdock, is estimated to be about $1.08M . Terry Murdock owns about 36,439 units of G1 Therapeutics, Inc common stock. In the last 6 years at G1 Therapeutics, Inc, Terry Murdock has sold an estimated value of $875.86K worth.

What is Terry Murdock's Past Insider Trading?

Terry Murdock's largest purchase order was 3,523 units , worth over $47.6K on December 3, 2018. Terry Murdock's largest sale order was 3,519 units , worth over $211.06K on September 6, 2018. In total, Terry Murdock has made about 14 transactions over 6 years of their time at G1 Therapeutics, Inc. Terry Murdock usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 2,368 units , worth over $13.08K on January 5, 2023.

TERRY MURDOCK

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

What are G1 Therapeutics, Inc's Past Insider Trades?

G1 Therapeutics, Inc's most recent insider trade came on January 5, 2023 by Jennifer Moses who sold 2,368 units worth $13.08K . In the last 6 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $69.69M and bought an estimated value of $25.76M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO .

G1 Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1